BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20345479)

  • 1. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma.
    Deng YB; Nagae G; Midorikawa Y; Yagi K; Tsutsumi S; Yamamoto S; Hasegawa K; Kokudo N; Aburatani H; Kaneda A
    Cancer Sci; 2010 Jun; 101(6):1501-10. PubMed ID: 20345479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
    Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
    Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
    Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
    Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
    Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
    Lv X; Ye G; Zhang X; Huang T
    Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
    Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
    Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.
    Formeister EJ; Tsuchiya M; Fujii H; Shpyleva S; Pogribny IP; Rusyn I
    Mutat Res; 2010 Oct; 692(1-2):26-33. PubMed ID: 20736025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
    Zheng Y; Hlady RA; Joyce BT; Robertson KD; He C; Nannini DR; Kibbe WA; Achenbach CJ; Murphy RL; Roberts LR; Hou L
    Clin Epigenetics; 2019 Oct; 11(1):145. PubMed ID: 31639042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of RASSF1A hypermethylation with risk of HBV/HCV-induced hepatocellular carcinoma: A meta-analysis.
    Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
    Pathol Res Pract; 2020 Oct; 216(10):153099. PubMed ID: 32853942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of TAF1, SAT1, and ARHGEF9 as DNA methylation biomarkers for hepatocellular carcinoma.
    Cai C; Xie X; Zhou J; Fang X; Wang F; Wang M
    J Cell Physiol; 2020 Jan; 235(1):611-618. PubMed ID: 31283007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of p14 (ARF) , RB, and INK4 gene family in hepatocellular carcinoma with hepatitis B virus infection.
    Zhang JC; Gao B; Yu ZT; Liu XB; Lu J; Xie F; Luo HJ; Li HP
    Tumour Biol; 2014 Mar; 35(3):2795-802. PubMed ID: 24254306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative methylation analysis reveals distinct association between PAX6 methylation and clinical characteristics with different viral infections in hepatocellular carcinoma.
    Shih YL; Kuo CC; Yan MD; Lin YW; Hsieh CB; Hsieh TY
    Clin Epigenetics; 2016; 8():41. PubMed ID: 27110298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
    Hinrichsen I; Kemp M; Peveling-Oberhag J; Passmann S; Plotz G; Zeuzem S; Brieger A
    PLoS One; 2014; 9(1):e84453. PubMed ID: 24400091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.
    Feng Q; Stern JE; Hawes SE; Lu H; Jiang M; Kiviat NB
    Exp Mol Pathol; 2010 Apr; 88(2):287-92. PubMed ID: 20079733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
    Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A
    Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
    Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
    J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E
    Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.